Aeterna Zentaris Inc. (AEZS:NASDAQ) shot up at $0.25, a gain of 40%. On Wed, Jun 29, 2022, AEZS:NASDAQ touched a New 2-Week High of $0.25. The stock got featured on our News Catalysts scanner on Mon, Jun 13, 2022 at 09:05 AM in the 'BIOTECH' category. From Wed, Jun 15, 2022, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Wed, Jun 29, 2022 at $0.35 with a volume of 26M+.
About Aeterna Zentaris Inc. (AEZS:NASDAQ)
AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women's health.
Top 10 Gainers:
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 114.29%
- Brickell Biotech, Inc. (BBI:NASDAQ), 47.64%
- Decibel Therapeutics Inc. (DBTX:NASDAQ), 44.15%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 39.98%
- Aditxt Inc. (ADTX:NASDAQ), 39.76%
- PARTS iD Inc. Class A (ID:NYSEMKT), 38.24%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 32.04%
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 29.45%
- 9F Inc. (JFU:NASDAQ), 28.01%